Study about the efficacy of lorazepam as a premedication for the disabled patients showing serious maladaptive behaviors in dentistry
Phase 4
Completed
- Conditions
- The intellectual disabled patients (The patients having a history of showing serious maladaptive behaviors in dentistry within the past one year)
- Registration Number
- JPRN-UMIN000014450
- Lead Sponsor
- Ogata Pediatric Dental Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who are contraindicated to benzodiazepine drugs (acute narrow-angle glaucoma, nuero-muscle disease). 2)Consultation is needed about an indication of lorazepam, to a regular doctor if a subject is administered other psychotropic drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of lorazepam is assessed on the day of general anesthesia or procedure of dentistry, about 2 hours after the last administration of lorazepam.
- Secondary Outcome Measures
Name Time Method The anticipated maladaptative behaviors (such as inability of coming to a clinic, inability of entering the operating room, inability of sitting down on a dental chair, or running away ect.) are scored according to the degree of serious level. The scored points corresponding to maladaptative behaviors after lorazepam premedication, are compared with those in the past hitory.